There is great variability in donor heart acceptance decisions among US transplant centers.
The presence of hyperlipidemia following hospitalization for acute myocardial infarction or acute decompensated heart failure may be associated with reduced mortality.
Increased risk for heart failure also seen in group of participants without diastolic dysfunction
Although widely used risk scores provide insight into the prognosis of patients with heart failure, they should be improved to take into account sex- and group-specific disease phenotypes and etiologies.
A machine learning model improves the prediction of long-term risks for myocardial infarction and cardiac death.
The FDA has accepted the sNDA and granted Priority Review for Farxiga for CV death and worsening of heart failure.
There may be an increased risk for ischemic stroke in elderly patients with intracerebral hemorrhage in the first 6 months after diagnosis.
Among patients with asthma and chronic obstructive pulmonary disease overlap, long-acting beta2-agonist therapy is associated with a decreased risk for myocardial infarction.
Risk score identifies risk among patients with acute leukemia treated with anthracyclines before chemotherapy.
Hypertrophic cardiomyopathy in black vs white patients may be associated with a greater burden of functional heart failure and reduced access to care and genetic testing.